MolecuLight

MolecuLight Inc. a privately-owned medical imaging company that has developed and is commercializing its proprietary fluorescent imaging platform technology in multiple clinical markets. MolecuLights suite of commercially released devices, including the MolecuLight i:X and DXTM fluorescence imaging systems and their accessories, provide point-of-care handheld imaging devices for the global wound care market for the real-time detection of wounds containing elevated bacterial burden > 10^4 CFU/g (when used with clinical signs and symptoms) and for digital wound measurement #moleculight

Fluorescence imaging,wound care,point-of-care imaging,limb salvage,advanced wound care therapies,wound healing,digital wound measurement,wound measurement tools,antimicrobial stewardship,imaging of bacterial burden,wound cleaning,wound debridement,vascular surgery,wound healing,diabetic foot ulcers,pressure ulcers,surgical site infections,podiatry,and biofilm

Moleculight operates in the Medical equipment manufacturing industry.

Moleculight's revenue is 11m - 100m

Moleculight has 51 - 200 employees.